Akt-FOXO1通路失调导致银屑病患者调节性T细胞功能障碍
研究发现银屑病患者循环CD4+CD25+FOXP3+ Treg比例与健康对照相当,但抑制功能降低。银屑病Treg高表达T-bet和IFN-γ,且蛋白激酶B介导的FOXO1磷酸化增加导致FOXO1核排除失活,进而不能抑制TBX21表达。Foxo1缺陷Treg不能保护银屑病样小鼠,提示Akt-FOXO1通路失调是Treg功能障碍的关键原因。
要点
- 银屑病Treg数量正常但抑制功能受损
- Akt介导FOXO1磷酸化核排除导致Treg失能
- FOXO1通过抑制TBX21维持Treg抑制功能
核心结论
- 蛋白激酶B-FOXO1通路失调可能是银屑病Treg功能障碍的关键原因。
研究设计与样本
- 研究比较银屑病患者与健康对照的循环Treg比例和抑制功能,并进行mRNA芯片分析。
- 采用银屑病样小鼠模型验证Foxo1缺陷Treg的保护作用。
主要发现
- 银屑病患者与健康对照的循环CD4+CD25+FOXP3+ Treg比例相当,但银屑病Treg抑制功能降低。
- 银屑病Treg高表达T-bet和IFN-γ等Th1样转录因子和细胞因子。
- 银屑病Treg中蛋白激酶B介导的FOXO1磷酸化增加,导致FOXO1核排除失活。
- 健康Treg与银屑病血清孵育后出现蛋白激酶B激活、FOXO1核排除及FOXO1转录活性丧失。
- Foxo1缺陷Treg不能保护银屑病样小鼠免于发病。
临床怎么用
- 靶向Akt-FOXO1通路可能恢复银屑病Treg抑制功能,为治疗提供新思路。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Psoriasis is a T lymphocyte-driven systemic inflammatory disease. Regulatory T cells (Tregs) are essential for establishing and maintaining immune tolerance. In this study, we found that patients with psoriasis and healthy controls had comparable percentages of circulating CD4+CD25+FOXP3+ Tregs, but psoriatic Tregs had reduced suppressive function. Thereafter, mRNA arrays were performed to study the gene expression profile of psoriatic Tregs. Psoriatic Tregs expressed high levels of a T helper type 1-like transcription factor and cytokines such as T-bet and IFN-γ. Furthermore, we found that FOXO1 can bind to the promoter of TBX21 to inhibit its expression, thus keeping the suppressive function of Tregs. However, an increase in protein kinase B-mediated phosphorylation of FOXO1 was observed in psoriatic Tregs, which subsequently caused FOXO1 inactivation by nuclear exclusion. In addition, incubation of healthy Tregs with psoriatic serum led to the activation of protein kinase B, nuclear exclusion of FOXO1, and the loss of FOXO1 transcription activity. The role of FOXO1 in regulating the function of Tregs was corroborated using a psoriasis-like mouse model in which Foxo1-deficient Tregs failed to protect mice from developing psoriasis. In conclusion, our findings reveal that the dysregulation of the protein kinase B-FOXO1 pathway may be a critical cause of Treg dysfunction in psoriasis.
引用
- Li B, Lei J, Yang L, et al. Dysregulation of Akt-FOXO1 Pathway Leads to Dysfunction of Regulatory T Cells in Patients with Psoriasis. J Invest Dermatol. 2019. PMID: 30998985. doi:10.1016/j.jid.2018.12.035
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。